Total Payments
$5,617
2024 Payments
$537.04
Companies
23
Transactions
136
Medicare Patients
1,800
Medicare Billing
$371,923
Payment Breakdown by Category
Food & Beverage$4,488 (79.9%)
Travel$1,129 (20.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,488 | 132 | 79.9% |
| Travel and Lodging | $1,129 | 4 | 20.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $1,186 | 5 | $0 (2019) |
| Abbott Laboratories | $1,154 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $562.94 | 18 | $0 (2024) |
| ENDOTRONIX, INC. | $352.83 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $336.76 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $300.96 | 13 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $285.38 | 12 | $0 (2023) |
| PFIZER INC. | $204.20 | 9 | $0 (2024) |
| Daiichi Sankyo Inc. | $203.83 | 9 | $0 (2023) |
| iRhythm Technologies, Inc. | $195.30 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $537.04 | 16 | Abbott Laboratories ($158.19) |
| 2023 | $1,031 | 43 | Abbott Laboratories ($223.55) |
| 2022 | $681.50 | 15 | ENDOTRONIX, INC. ($228.26) |
| 2021 | $363.04 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($136.42) |
| 2020 | $44.81 | 2 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($24.50) |
| 2019 | $1,729 | 18 | Medtronic Vascular, Inc. ($1,050) |
| 2018 | $895.79 | 22 | Abbott Laboratories ($411.54) |
| 2017 | $334.40 | 9 | Medtronic Vascular, Inc. ($135.52) |
All Payment Transactions
136 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/27/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Ancora Heart, Inc. | AccuCinch (Device) | Food and Beverage | Cash or cash equivalent | $39.27 | General |
| Category: Cardiovascular | ||||||
| 10/26/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Travel and Lodging | In-kind items and services | $134.41 | General |
| Category: Heart Failure | ||||||
| 10/26/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Heart Failure | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $90.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Heart Failure | ||||||
| 09/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Cardiology | ||||||
| 07/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/17/2024 | One Lambda, Inc. | — | Food and Beverage | Cash or cash equivalent | $33.64 | General |
| 04/04/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/27/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $33.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/25/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: Heart Failure | ||||||
| 12/19/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/16/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/27/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Heart Failure | ||||||
| 10/18/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $45.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 548 | 982 | $702,359 | $106,170 |
| 2022 | 14 | 544 | 1,067 | $742,283 | $115,033 |
| 2021 | 13 | 510 | 934 | $731,156 | $110,819 |
| 2020 | 9 | 198 | 362 | $230,823 | $39,901 |
Total Patients
1,800
Total Services
3,345
Medicare Billing
$371,923
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 89 | 189 | $140,805 | $29,632 | 21.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 42 | 114 | $161,310 | $21,947 | 13.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 61 | 175 | $125,125 | $18,581 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 83 | $45,650 | $8,924 | 19.5% |
| 93505 | Biopsy of heart muscle | Facility | 2023 | 26 | 38 | $49,584 | $7,876 | 15.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 38 | 41 | $28,700 | $4,753 | 16.6% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 37 | 49 | $54,714 | $3,818 | 7.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $14,910 | $2,793 | 18.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 39 | $20,241 | $2,769 | 13.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $19,824 | $2,178 | 11.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 89 | 156 | $22,620 | $2,017 | 8.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 33 | 44 | $13,728 | $506.88 | 3.7% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 11 | 11 | $4,840 | $249.92 | 5.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 13 | 15 | $308.00 | $126.00 | 40.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 85 | 188 | $140,060 | $30,678 | 21.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 67 | 210 | $149,256 | $19,808 | 13.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 24 | 97 | $132,517 | $19,743 | 14.9% |
| 93505 | Biopsy of heart muscle | Facility | 2022 | 20 | 43 | $53,406 | $9,273 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 75 | $41,250 | $8,534 | 20.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 27 | 28 | $39,648 | $5,150 | 13.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $23,430 | $4,604 | 19.7% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2022 | 32 | 58 | $60,204 | $4,516 | 7.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 61 | $31,659 | $4,008 | 12.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 19 | 20 | $14,900 | $2,554 | 17.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 95 | 177 | $25,665 | $2,424 | 9.4% |
About Dr. Bernard Kadosh, M.D
Dr. Bernard Kadosh, M.D is a Cardiovascular Disease healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2013. The National Provider Identifier (NPI) number assigned to this provider is 1861836645.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bernard Kadosh, M.D has received a total of $5,617 in payments from pharmaceutical and medical device companies, with $537.04 received in 2024. These payments were reported across 136 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,488).
As a Medicare-enrolled provider, Kadosh has provided services to 1,800 Medicare beneficiaries, totaling 3,345 services with total Medicare billing of $371,923. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Advanced Heart Failure and Transplant Cardiology
- Location New York, NY
- Active Since 04/23/2013
- Last Updated 02/03/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1861836645
Products in Payments
- ENTRESTO (Drug) $448.82
- CardioMEMS HF System (Device) $358.00
- CORDELLA PULOMONARY ARTERY PRESSURE SENSOR (Device) $352.83
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $314.51
- XARELTO (Drug) $300.96
- JARDIANCE (Drug) $285.38
- CARDIOMEMS (Device) $214.73
- INJECTAFER (Drug) $203.83
- ICDs (Device) $180.43
- LifeVest (Device) $175.45
- VYNDAQEL (Drug) $170.03
- VERQUVO (Drug) $153.10
- Resolute (Device) $135.52
- FARXIGA (Drug) $118.87
- ZIO Patch (Device) $115.58
- LEQVIO (Drug) $114.12
- Impella (Device) $90.60
- ZIO XT Patch (Device) $79.72
- BRILINTA (Drug) $77.10
- FUROSCIX (Drug) $54.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in New York
Dr. Roger Hajjar, Md, MD
Cardiovascular Disease — Payments: $5.2M
Cardiovascular Disease $5.2M
Dr. Jacob Koruth, M.d, M.D
Cardiovascular Disease — Payments: $3.2M
Cardiovascular Disease $3.2M
Dr. Martin Leon, M.d, M.D
Cardiovascular Disease — Payments: $2.7M
Cardiovascular Disease $2.7M
Dr. Gregg Stone, M.d, M.D
Cardiovascular Disease — Payments: $2.2M
Cardiovascular Disease $2.2M
Adam Rosenbluth, Md, MD
Cardiovascular Disease — Payments: $1.5M
Cardiovascular Disease $1.5M
Dr. Deepak Bhatt, Md, MD
Cardiovascular Disease — Payments: $1.4M
Cardiovascular Disease $1.4M